Access cutting-edge triple negative breast cancer treatment through this clinical trial at a research site in New Brunswick. Study-provided care at no cost to qualified participants.
Access triple negative breast cancer specialists in New Brunswick at no cost
This study follows strict safety protocols and ethical guidelines
All study-related triple negative breast cancer treatment provided free
This is an open label, multi-institutional, single arm phase II trial of ribociclib in combination with bicalutamide in advanced AR+ triple-negative breast cancer. No randomization or blinding is involved.
Sponsor: Kari Wisinski
Check if you qualify for this triple negative breast cancer clinical trial in New Brunswick, NJ
If you're searching for triple negative breast cancer treatment options in New Brunswick, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Brunswick research site is actively enrolling participants for this clinical trial. You'll receive care from experienced triple negative breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.